Semaglutide Delivers 14–17% Weight Loss in Landmark Review, but Gains Fade After Stopping
A new systematic review of 15 studies confirms semaglutide's clinically meaningful weight-loss benefits while cautioning that results vary by dose, ...
Tag: semaglutide
Landmark Nordic Registry Study Rules Out Pancreatic Cancer Risk From Semaglutide
A regulator-mandated study using nationwide registry data from Denmark, Sweden and Norway found no increased risk of pancreatic cancer among ...
GLP-1 Drugs Take Centre Stage as UK Obesity Congress Reveals New Evidence on Care, Stigma and Scale
New research presented at the 11th UK Congress on Obesity in Sheffield shows GLP-1 medications are reshaping treatment while behavioural ...
Ozempic’s Ripple Effect: What Patients Know, and How One Prescription Can Reshape a Household
A survey of diverse patients in a Philadelphia health system found that most understand the main uses and side effects ...
Tirzepatide Outperforms Semaglutide on Weight and Metabolic Health in New Comparison
An indirect treatment comparison of the SURMOUNT-1 and STEP 1 trials finds tirzepatide 10 and 15 mg delivers greater weight ...
One in Forty Swiss Adults Has Used Ozempic-Style Drugs, and Some Are Sharing Them
A nationally representative Swiss survey finds that 2.5 percent of the population has used GLP-1 receptor agonists, mostly for weight ...
Semaglutide Shifts Inflammation Blood Markers in Diabetes, With a Twist for Eye Disease
A retrospective study of 99 patients in Saudi Arabia found that semaglutide significantly altered systemic inflammation index ratios in type ...
Do Weight-Loss Drugs Help or Harm Mental Health? A Major Analysis Finds the Evidence Strikingly Thin
A Bayesian network meta-analysis of randomized trials finds that approved anti-obesity medications show no clear effect on depression, uncertain effects ...
Widely Used Weight-Loss Drugs Linked to Sharply Lower Heart Risks in Sleep Apnea Patients
A large real-world study finds that GLP-1 receptor agonists are associated with significantly reduced risks of heart failure, pulmonary hypertension, ...
Diabetes Drugs That Quietly Lower Blood Pressure: Inside the GLP-1 Mechanism
A new review synthesizes molecular, renal and clinical evidence showing that GLP-1 receptor agonists lower systolic blood pressure through converging ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!